News

The objective of extending collaboration is to identify, develop and commercialize drugs to treat neurodegenerative diseases, ophthalmology and pain. Exonhit CEO Loic Maurel said the collaboration has created

CK-2017357 is a skeletal muscle troponin activator which increases its sensitivity to calcium and delays the onset and reduces the degree of muscle fatigue. The double-blind, placebo-controlled, randomized,

Under the agreement, Evonik will acquire the complete portfolio of products and services of SurModics Pharmaceuticals, including the company’s cGMP development and manufacturing facility situated in Birmingham, Alabama.

The tumor-targeting system, which will use human autoimmune antibodies, is expected to enhance the safety and effectiveness of current cancer drugs by improving localization at the tumor site.

Epinastine HCl is a generic version of Merck’s eye drug Elestat. Elestat comprises epinastine used to prevent ocular itching associated with allergic conjunctivitis. Perrigo chairman and CEO Joseph

NU100 is a proprietary recombinant human interferon beta-1b (IFN beta-1b) which utilizes the company’s refolding process technology being developed as a new molecular entity. The double-blind, placebo-controlled, randomized

In order to eradicate and predict HIV, investigators of both companies decided to develop methods to characterize potential latency candidates and discover and validate targets and pathways to

The NOA will allow the California- based biotech company to identify differentially expressed proteins in cell samples. The method, which uses libraries of antibodies, has a wide range

GSK will provide funding and certain milestone payments to Alnylam, as per the deal. VaxiRNA is an RNAi technology for the enhanced production of viruses used in the